Form 4: Iradimed Director Monty K. Allen Receives Restricted Stock Units

Director Monty K. Allen of Iradimed Corporation was granted 1,811 restricted stock units under the company's 2023 Equity Incentive Plan.

Summary

• Monty K. Allen, a director at Iradimed Corporation, received 1,811 restricted stock units on December 11, 2024.
• These restricted stock units were granted under the company's 2023 Equity Incentive Plan.
• The units will vest in two equal annual installments, starting on December 11, 2025.
• Upon vesting, each unit will convert into one share of Iradimed common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of incentivizing directors with equity, which is generally viewed positively. There are no negative implications.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock units will vest over the next two years, potentially increasing the director's shareholding in the company.

Industry Context

Granting restricted stock units to directors is a common practice to incentivize and align their interests with the company's long-term performance.

Comparison to Industry Standards

• Many companies in the medical device industry use equity-based compensation to attract and retain key personnel.
• The vesting schedule of two years is fairly standard for restricted stock unit grants.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning director interests with company performance.
• Employees may see this as a standard practice for incentivizing leadership.

Key Dates

Keywords

restricted stock units, equity incentive plan, director, Iradimed, stock, vesting